FKBP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.529000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.549400E-01
Normal-vs-Stage2
1.500020E-01
Normal-vs-Stage3
3.666200E-01
Normal-vs-Stage4
2.511400E-01
Stage1-vs-Stage2
3.392000E-01
Stage1-vs-Stage3
3.386200E-01
Stage1-vs-Stage4
3.094600E-01
Stage2-vs-Stage3
9.140000E-01
Stage2-vs-Stage4
5.976200E-01
Stage3-vs-Stage4
7.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.649000E-01
Normal-vs-AfricanAmerican
1.982230E-01
Normal-vs-Asian
7.038300E-02
Caucasian-vs-AfricanAmerican
9.024200E-01
Caucasian-vs-Asian
4.822400E-01
AfricanAmerican-vs-Asian
8.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.811400E-01
Normal-vs-Female
4.128400E-01
Male-vs-Female
8.185200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.980000E-01
Normal-vs-Age(41-60Yrs)
5.237000E-01
Normal-vs-Age(61-80Yrs)
1.575210E-01
Normal-vs-Age(81-100Yrs)
5.913700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.857000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.522800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.488800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.483200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.158600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.990800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.218440E-01
Normal-vs-Daily Drinker
1.458600E-01
Normal-vs-Weekly Drinker
1.144750E-01
Normal-vs-Occasional Drinker
1.156590E-01
Normal-vs-Social Drinker
1.589600E-01
Non Drinker-vs-Daily Drinker
4.262300E-02
Non Drinker-vs-Weekly Drinker
8.188600E-01
Non Drinker-vs-Occasional Drinker
2.348400E-01
Non Drinker-vs-Social Drinker
2.985800E-01
Daily Drinker-vs-Weekly Drinker
6.880000E-02
Daily Drinker-vs-Occasional Drinker
5.252000E-01
Daily Drinker-vs-Social Drinker
3.574200E-01
Weekly Drinker-vs-Occasional Drinker
2.504200E-01
Weekly Drinker-vs-Social Drinker
4.149200E-01
Occasional Drinker-vs-Social Drinker
3.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.615200E-01
Normal-vs-Grade 2
5.354800E-01
Normal-vs-Grade 3
5.549200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.559700E-02
Grade 1-vs-Grade 3
4.256000E-02
Grade 1-vs-Grade 4
5.615200E-01
Grade 2-vs-Grade 3
2.537600E-01
Grade 2-vs-Grade 4
5.354800E-01
Grade 3-vs-Grade 4
5.549200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.897200E-01
Normal-vs-NonDiabetic
3.162200E-01
Diabetic-vs-NonDiabetic
8.906600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.721700E-02
Normal-vs-NoPancreatitis
4.834600E-01
Pancreatitis-vs-NoPancreatitis
8.350000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.063840E-01
Normal-vs-N1
1.703180E-01
N0-vs-N1
1.029730E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.125800E-02
Normal-vs-TP53-NonMutant
2.018200E-02
TP53-Mutant-vs-TP53-NonMutant
1.900610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
